SARS-CoV-2 Omicron BA.1 breakthrough infection drives late remodeling of the memory B cell repertoire in vaccinated individuals

Aurélien Sokal,Giovanna Barba-Spaeth,Lise Hunault,Ignacio Fernández,Matteo Broketa,Annalisa Meola,Slim Fourati,Imane Azzaoui,Alexis Vandenberghe,Pauline Lagouge-Roussey,Manon Broutin,Anais Roeser,Magali Bouvier-Alias,Etienne Crickx,Laetitia Languille,Morgane Fournier,Marc Michel,Bertrand Godeau,Sébastien Gallien,Giovanna Melica,Yann Nguyen,Florence Canoui-Poitrine,France Pirenne,Jérôme Megret,Jean-Michel Pawlotsky,Simon Fillatreau,Claude-Agnès Reynaud,Jean-Claude Weill,Félix A Rey,Pierre Bruhns,Matthieu Mahévas,Pascal Chappert
DOI: https://doi.org/10.1016/j.immuni.2023.07.007
IF: 32.4
2023-09-12
Immunity
Abstract:How infection by a viral variant showing antigenic drift impacts a preformed mature human memory B cell (MBC) repertoire remains an open question. Here, we studied the MBC response up to 6 months after SARS-CoV-2 Omicron BA.1 breakthrough infection in individuals previously vaccinated with three doses of the COVID-19 mRNA vaccine. Longitudinal analysis, using single-cell multi-omics and functional analysis of monoclonal antibodies from RBD-specific MBCs, revealed that a BA.1 breakthrough infection mostly recruited pre-existing cross-reactive MBCs with limited de novo response against BA.1-restricted epitopes. Reorganization of clonal hierarchy and new rounds of germinal center reactions, however, combined to maintain diversity and induce progressive maturation of the MBC repertoire against common Hu-1 and BA.1, but not BA.5-restricted, SARS-CoV-2 Spike RBD epitopes. Such remodeling was further associated with a marked improvement in overall neutralizing breadth and potency. These findings have fundamental implications for the design of future vaccination booster strategies.
What problem does this paper attempt to address?